PHREESIA INC (PHR) Stock Price, Quote, News and Overview
NYSE:PHR - New York Stock Exchange, Inc. - US71944F1066 - Common Stock - Currency: USD
PHR Quote, Performance and Key Statistics
PHREESIA INC
NYSE:PHR (1/24/2025, 6:40:00 PM)
After market: 27.89 0 (0%)27.89
+0.61 (+2.24%)
The current stock price of PHR is 27.89 USD. In the past month the price increased by 9.89%. In the past year, price increased by 10.46%.
PHR Latest News, Press Releases and Analysis
Here's Why Phreesia's Average Revenue Per Client Will Accelerate: Analyst
Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients. Upgraded rating and PT raised.
Phreesia Announces Third Quarter Fiscal 2025 Results
Phreesia Named to The Software Report’s “Top 100 Software Companies” for the Third Consecutive Year
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
PHR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 35.74 | 36.27B | ||
| DOCS | DOXIMITY INC-CLASS A | 50.5 | 10.56B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 6.72B | ||
| CERT | CERTARA INC | 34 | 2.13B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 15.47 | 1.89B | ||
| SDGR | SCHRODINGER INC | N/A | 1.80B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.74B | ||
| EVH | EVOLENT HEALTH INC - A | 11.1 | 1.18B | ||
| HSTM | HEALTHSTREAM INC | 49.54 | 979.20M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 953.14M | ||
| DH | DEFINITIVE HEALTHCARE CORP | 14.21 | 748.55M | ||
| SLP | SIMULATIONS PLUS INC | 60.32 | 678.64M |
Related stock screener links
About PHR
Company Profile
Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Wilmington, Delaware and currently employs 1,438 full-time employees. The company went IPO on 2019-07-18. The firm's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The firm also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The firm's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Company Info
PHREESIA INC
1521 Concord Pike, Suite 301 Pmb 221
Wilmington DELAWARE 27601 US
CEO: Chaim Indig
Employees: 1438
Company Website: https://www.phreesia.com
Investor Relations: https://ir.phreesia.com/
Phone: 18886547473
PHR FAQ
What is the stock price of PHR?
The current stock price of PHR is 27.89 USD.
What is the symbol for PHREESIA INC stock?
The exchange symbol of PHREESIA INC is PHR and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is PHR stock listed?
PHR stock is listed on the New York Stock Exchange, Inc. exchange.
Is PHR a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PHR, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PHR.
Does PHR stock pay dividends?
PHR does not pay a dividend.
What is the Price/Earnings (PE) ratio of PHR?
PHR does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.12).
What is the Short Interest ratio of PHR stock?
The outstanding short interest for PHR is 5.11% of its float.
PHR Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to PHR. When comparing the yearly performance of all stocks, PHR is one of the better performing stocks in the market, outperforming 87.21% of all stocks.
PHR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PHR. The financial health of PHR is average, but there are quite some concerns on its profitability.
PHR Financial Highlights
Over the last trailing twelve months PHR reported a non-GAAP Earnings per Share(EPS) of -1.12. The EPS increased by 20% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -22.03% | ||
| ROE | -32.52% | ||
| Debt/Equity | 0.04 |
PHR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to PHR. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 0.48% and a revenue growth 20.1% for PHR